SeaStar Medical (NASDAQ:ICU) Cut to “Sell” at Wall Street Zen

Wall Street Zen lowered shares of SeaStar Medical (NASDAQ:ICU – Free Report) from a hold rating to a sell rating in a report released on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SeaStar Medical in a report on Thursday, October 15th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $8.00.

View Our Latest Stock Report on SeaStar Medical

SeaStar Medical Trading Up 1.8%

Shares of ICU opened at $0.85 on Friday. The firm has a market capitalization of $4.54 million, a P/E ratio of -0.23 and a beta of -1.07. The stock’s fifty day simple moving average is $2.89 and its 200 day simple moving average is $3.27. SeaStar Medical has a twelve month low of $0.79 and a twelve month high of $5.38.

SeaStar Medical (NASDAQ:ICU – Get Free Report) last issued its earnings results on Wednesday, November 11th. The company reported ($1.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.95) by ($0.08). SeaStar Medical had a negative net margin of 678.24% and a negative return on equity of 199.99%. The firm had revenue of $0.64 million during the quarter, compared to analyst estimates of $0.50 million. Sell-side analysts predict that SeaStar Medical will post -3.66 earnings per share for the current year.

About SeaStar Medical

(Get Free Report)

SeaStar Medical Holding Corp. is a medical technology company developing extracorporeal therapies intended to address harmful inflammation in patients with critical illnesses. Its approach uses the Selective Cytopheretic Device (SCD), which processes blood outside the body and is designed to target activated immune cells associated with inflammation. The company’s lead product, QUELIMMUNE, is an SCD-based therapy for certain pediatric patients with acute kidney injury and sepsis or a septic condition who require continuous kidney replacement therapy.

Further Reading

Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.